Alignment Healthcare, Inc. Common Stock
Here’s whether Alignment Healthcare, Inc. Common Stock (ALHC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-1.67% over 10 days); RSI 25 — oversold; 3-month momentum negative (-11.2%); rising volume on a downtrend (distribution, 1.18x avg). Currently 44.4% off its 52-week high. Score: -6/7.
ALHC is trading below its 200-day MA ($19.14) — a key warning sign the longer-term trend is under pressure. An RSI of 24.6 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -5.8% compares to +20.4% for SPY (trailed the market by 26.2%). The current 44.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.